- Status:
- Awaiting development
- Technology type:
- Medicine
- Decision:
- None selected
- Process:
- STA Standard
- ID number:
- 3894
Timeline
Key events during the development of the guidance:
| Date | Update |
|---|---|
| 20 November 2025 | Awaiting development. Following on from information received from the company, the timelines for this appraisal are to be confirmed whilst the company confirm their regulatory filing plans. As this appraisal has been referred, NICE will continue to monitor any development and will update interested parties if the situation changes. |
| 30 September 2025 | In progress. Please note that following on from advice received from the company this appraisal has been rescheduled to align with latest regulatory expectations. Therefore, we now anticipate that the appraisal will begin during early September 2026 when we will write to you about how you can get involved. |
| 23 January 2025 | Please note that following on from advice received from the company this appraisal has been rescheduled to align with latest regulatory expectations. Therefore, we now anticipate that the appraisal will begin during early August 2026 when we will write to you about how you can get involved. The deadline for submissions is expected in approximately early October 2026. |
| 24 March 2021 | Please note that following on from advice received from the company this appraisal will be rescheduled to align with latest regulatory expectations. Further information regarding the timelines for this appraisal will be available in due course. |
For further information on our processes and methods, please see our CHTE processes and methods manual